
Europe Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)
Description
Europe Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)
The Europe cerebrospinal fluid management market is expected to reach US$ 988.78 million by 2028 from US$ 694.04 million in 2021; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The growth of the market is attributed to rising technological developments for CSF shunts and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.
The never-ending technological developments are the unstoppable trend for the growth of CSF management market. The risk of diagnosing and treatment failure, limited control options, and complications have offered various opportunities for the product developers. Rising advancements in technology have introduced the concept of “smart shunt” that could offer hi-tech control, diagnosis, and communication-based shunts or implants. It is anticipated that designed smart shunts can control CSF drainage based on feedback from one or more measured conditions. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical shunts—data with respect to shunt malfunction. It is further expected to reduce the risk of shunt obstructions and eventually reduce the risk of failures.
Late-stage development companies operating in the market are demanding experimental results to seek approvals and commercialize the smart shunts. The primary focus is on shunts designed to assess ICP noninvasively in the physician’s office through an implanted pressure sensor and noninvasive assessment of CSF flow in the clinical settings. These on-demand sensing systems will be a significantly advanced supplement to existing mechanical valves.
The growing demand for better treatments has resulted in various product developments, resulting in the Europe cerebrospinal fluid management market growth. For instance, in July 2018, FDA granted breakthrough device designation to F. Hoffmann-La Roche Ltd for its Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF. The products are used as in-vitro diagnostic immunoassays to measure ß-Amyloid (1-42) and Phospho-Tau concentrations in CSF among adults with cognitive impairment. They are evaluated for Alzheimer’s disease (AD) and other causes of dementia.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most-affected European countries. The COVID-19 emergency has undoubtedly aided in encouraging the general population to try out and expand their usage of digital services, particularly to avoid visiting a health center in person. However, there are still a number of constraints that hinder these services from becoming widely adopted.
Inconsistent and interrupted supply chain activities and unavailability of human resources negatively impacted the cerebrospinal fluid management market growth. The sudden onset of pandemic led to shutdown of neurological wards and clinics across numerous countries. At the same time, hospitals ran out of resources owing to a huge number of COVID-19 patients. Consequently, according to one study, many diagnostic and treatment procedures had been cancelled or postponed around the world.
The Europe cerebrospinal fluid management market, by product, is segmented into CSF shunts and CSF drainage systems. In 2021, the CSF shunts segment held a larger share of the market. Also, the same segment is estimated to register a higher CAGR during the forecast period due to the growing number of product launches, increasing demand for advanced CSF shunts, and rising incidences of hydrocephalus.
The Europe cerebrospinal fluid management market, by end user, is segmented into hospitals, clinics, ambulatory surgical centers, and neurological centers. In 2021, the hospitals segment held the largest share of the market. However, the market for the clinics segment is expected to grow at the fastest rate in the coming years.
A few of the primary and secondary sources referred to while preparing the report on the Europe cerebrospinal fluid management market are National Health Service (NHS), German Cancer Society (Deutsche Krebsgesellschaft), and World Health Organization (WHO).
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe cerebrospinal fluid management market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The Europe cerebrospinal fluid management market is expected to reach US$ 988.78 million by 2028 from US$ 694.04 million in 2021; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The growth of the market is attributed to rising technological developments for CSF shunts and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.
The never-ending technological developments are the unstoppable trend for the growth of CSF management market. The risk of diagnosing and treatment failure, limited control options, and complications have offered various opportunities for the product developers. Rising advancements in technology have introduced the concept of “smart shunt” that could offer hi-tech control, diagnosis, and communication-based shunts or implants. It is anticipated that designed smart shunts can control CSF drainage based on feedback from one or more measured conditions. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical shunts—data with respect to shunt malfunction. It is further expected to reduce the risk of shunt obstructions and eventually reduce the risk of failures.
Late-stage development companies operating in the market are demanding experimental results to seek approvals and commercialize the smart shunts. The primary focus is on shunts designed to assess ICP noninvasively in the physician’s office through an implanted pressure sensor and noninvasive assessment of CSF flow in the clinical settings. These on-demand sensing systems will be a significantly advanced supplement to existing mechanical valves.
The growing demand for better treatments has resulted in various product developments, resulting in the Europe cerebrospinal fluid management market growth. For instance, in July 2018, FDA granted breakthrough device designation to F. Hoffmann-La Roche Ltd for its Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF. The products are used as in-vitro diagnostic immunoassays to measure ß-Amyloid (1-42) and Phospho-Tau concentrations in CSF among adults with cognitive impairment. They are evaluated for Alzheimer’s disease (AD) and other causes of dementia.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most-affected European countries. The COVID-19 emergency has undoubtedly aided in encouraging the general population to try out and expand their usage of digital services, particularly to avoid visiting a health center in person. However, there are still a number of constraints that hinder these services from becoming widely adopted.
Inconsistent and interrupted supply chain activities and unavailability of human resources negatively impacted the cerebrospinal fluid management market growth. The sudden onset of pandemic led to shutdown of neurological wards and clinics across numerous countries. At the same time, hospitals ran out of resources owing to a huge number of COVID-19 patients. Consequently, according to one study, many diagnostic and treatment procedures had been cancelled or postponed around the world.
The Europe cerebrospinal fluid management market, by product, is segmented into CSF shunts and CSF drainage systems. In 2021, the CSF shunts segment held a larger share of the market. Also, the same segment is estimated to register a higher CAGR during the forecast period due to the growing number of product launches, increasing demand for advanced CSF shunts, and rising incidences of hydrocephalus.
The Europe cerebrospinal fluid management market, by end user, is segmented into hospitals, clinics, ambulatory surgical centers, and neurological centers. In 2021, the hospitals segment held the largest share of the market. However, the market for the clinics segment is expected to grow at the fastest rate in the coming years.
A few of the primary and secondary sources referred to while preparing the report on the Europe cerebrospinal fluid management market are National Health Service (NHS), German Cancer Society (Deutsche Krebsgesellschaft), and World Health Organization (WHO).
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe cerebrospinal fluid management market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
133 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Cerebrospinal Fluid Management Market - By Product
- 1.3.2 Cerebrospinal Fluid Management Market - By End User
- 1.3.3 Cerebrospinal Fluid Management Market - By Country
- 2. Cerebrospinal Fluid Management Market - Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. Europe Cerebrospinal Fluid Management Market- Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Europe: PEST Analysis
- 4.3 Expert Opinion
- 5. Cerebrospinal Fluid Management Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Incidences of CSF Leak
- 5.1.2 Growing Developments for CSF Management Products
- 5.2 Market Restraints
- 5.2.1 Risk Associated with CSF Shunts
- 5.3 Future Trends
- 5.3.1 Technological Developments for CSF Shunts
- 5.4 Impact Analysis
- 6. Cerebrospinal Fluid Management Market - Europe Analysis
- 6.1 Europe Cerebrospinal Fluid Management Marker Revenue Forecast and Analysis
- 7. Cerebrospinal Fluid Management Market Analysis - By Product
- 7.1 Overview
- 7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product (2021 and 2028)
- 7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Ventriculo-Peritoneal Shunts
- 7.3.3.1 Overview
- 7.3.3.2 Ventriculo-Peritoneal Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Ventriculo-Atrial Shunts
- 7.3.4.1 Overview
- 7.3.4.2 Ventriculo-Atrial Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Ventriculo-Pleural Shunts
- 7.3.5.1 Overview
- 7.3.5.2 Ventriculo-Pleural Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Lumbo-Peritoneal Shunts
- 7.3.6.1 Overview
- 7.3.6.2 Lumbo-Peritoneal Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 xternal Ventricular Drainage (EVD) Systems
- 7.4.3.1 Overview
- 7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
- 7.4.4.1 Overview
- 7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 8. Cerebrospinal Fluid Management Market Analysis - By End User
- 8.1 Overview
- 8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User (2021 and 2028)
- 8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 8.6 Neurological Centers
- 8.6.1 Overview
- 8.6.2 Neurological Centers: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- 9. Cerebrospinal Fluid Management Market - Europe Analysis
- 9.1 Europe: Cerebrospinal Fluid Management Market
- 9.1.1 Overview
- 9.1.2 Europe: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.3 Europe: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.3.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.3.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028(USD Million)
- 9.1.4 Europe: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5 Europe: Cerebrospinal Fluid Management Market, by Country, 2021 & 2028 (%)
- 9.1.5.1 Germany: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.1.1 Germany: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.1.2 Germany: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.1.2.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.5.1.2.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.1.3 Germany: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5.2 UK: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.2.1 UK: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.2.2 UK: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.2.2.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.5.2.2.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.2.3 UK: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5.3 France: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.3.1 France: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.3.2 France: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.3.2.1 France Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.5.3.2.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.3.3 France: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5.4 Spain: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.4.1 Spain: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.4.2 Spain: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.4.2.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.5.4.2.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.4.3 Spain: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5.5 Italy: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.5.1 Italy: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.5.2 Italy: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.5.2.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts, 2019- 2028 (USD Million)
- 9.1.5.5.2.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.5.3 Italy: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 9.1.5.6 Rest of Europe: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.6.1 Rest of Europe: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- 9.1.5.6.2 Rest of Europe: Cerebrospinal Fluid Management Market, by Product, 2019-2028 (USD Million)
- 9.1.5.6.2.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
- 9.1.5.6.2.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019-2028 (USD Million)
- 9.1.5.6.3 Rest of Europe: Cerebrospinal Fluid Management Market, by End User, 2019-2028 (USD Million)
- 10. Impact of COVID-19 Pandemic on Europe Cerebrospinal Fluid Management Market
- 10.1 Europe: Impact Assessment of COVID-19 Pandemic
- 11. Cerebrospinal Fluid Management Market-Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
- 11.2.1 Overview
- 11.3 Inorganic Developments
- 11.3.1 Overview
- 12. Company Profiles
- 12.1 Medtronic
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Integra Life Sciences Corporation
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 B. Braun Melsungen AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 DePuy Synthes
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Sophysa
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Dispomedica GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Möller Medical GmbH
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Natus Medical Incorporated
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Spiegelberg GmbH & Co. KG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 13. Appendix
- 13.1 About the Insight Partners
- 13.2 Glossary of Terms
- list of Tables
- Table 1. Europe Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 20280(USD Million)
- Table 2. Europe Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 3. Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 4. Europe Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 5. Germany Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 6. Germany Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 7. Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 8. Germany Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 9. UK Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 10. UK Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 11. UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 12. UK Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 13. France Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 14. France Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 15. France Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 16. France Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 17. Spain Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 18. Spain Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 19. Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 20. Spain Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 21. Italy Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 22. Italy Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 23. Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019- 2028 (USD Million)
- Table 24. Italy Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 25. Rest of Europe: Cerebrospinal Fluid Management Market, by Product- Revenue and forecast to 2028 (USD Million)
- Table 26. Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts - Revenue and Forecast to 2028 (USD Million)
- Table 27. Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems - Revenue and Forecast to 2028 (USD Million)
- Table 28. Rest of Europe Cerebrospinal Fluid Management Market, by End User - Revenue and forecast to 2028 (USD Million)
- Table 29. Organic Developments Done by Companies
- Table 30. Inorganic Developments Done by Companies
- Table 31. Glossary of Terms, Cerebrospinal Fluid Management Market
- List of Figures
- Figure 1. Cerebrospinal Fluid Management Market Segmentation
- Figure 2. Cerebrospinal Fluid Management Market - By Country
- Figure 3. Cerebrospinal Fluid Management Market Overview
- Figure 4. CSF Shunts Segment Held Largest Share of Cerebrospinal Fluid Management Market by Product
- Figure 5. Cerebrospinal Fluid Management Market - Leading Country Markets (US$ Million)
- Figure 6. Europe: PEST Analysis
- Figure 7. Expert Opinion
- Figure 8. Cerebrospinal Fluid Management Market Impact Analysis of Drivers and Restraints
- Figure 9. Europe Cerebrospinal Fluid Management Market - Revenue Forecast and Analysis - 2021- 2028
- Figure 10. Cerebrospinal Fluid Management Market Revenue Share, by Product (2021 and 2028)
- Figure 11. CSF Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Ventriculo-Peritoneal Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Ventriculo-Atrial Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Ventriculo-Pleural Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Lumbo-Peritoneal Shunts: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 16. CSF Drainage Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 17. External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Cerebrospinal Fluid Management Market Revenue Share, by End User (2021 and 2028)
- Figure 20. Hospitals: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Clinics: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Neurological centers: Cerebrospinal Fluid Management Market- Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Europe: Cerebrospinal Fluid Management Market, by Key Country - Revenue (2021) (USD Million)
- Figure 25. Europe Cerebrospinal Fluid Management Market Revenue and forecast to 2028 (USD Million)
- Figure 26. Europe: Cerebrospinal Fluid Management Market, by Country, 2021 & 2028 (%)
- Figure 27. Germany: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 28. UK: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 29. France: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 30. Spain: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 31. Italy: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 32. Rest of Europe: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
- Figure 33. Impact of COVID-19 Pandemic in European Country Markets
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.